PROVIDER PROFILE · NPI 1225084411

Michel Bien-Aime

Psychiatry & NeurologyPhila, PAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

4,725

Beneficiaries

—

Total drug cost

$327K

Distinct drugs

Brand share

13.3%

Top prescribed drugs

Alprazolam406 claims

Mirtazapine395 claims

Trazodone Hcl328 claims

Quetiapine Fumarate324 claims

Clonazepam301 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Michel Bien-Aime's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
GREATER PHILADELPHIA HEALTH ACTION, INC	22	48
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Norristown, PA	18	25
Parkway Clinical Laboratories, Inc. Clinical Laboratory · Bensalem, PA	17	29
JEFFERSON HEALTH - NORTHEAST	12	18

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
GREATER PHILADELPHIA HEALTH ACTION INC.	50	328
Parkway Clinical Laboratories, Inc. Clinical Laboratory · Bensalem, PA	32	106
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Norristown, PA	13	24

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history